Harry L. Leider, MD, MBA, FACPE,

Chief Medical Officer and Senior Vice President

Dr. Harry Leider has a broad range of experience in clinical medicine and research, disease management and managed care. He utilizes his experience to lead a variety of progressive initiatives at Ameritox. His areas of responsibility include: directing the company’s clinical research projects, working with national experts in the area of chronic pain designing programs and tools that support practicing physicians, and designing and implementing programs that help payers improve quality of care for patients with chronic pain.

For more than 20 years, Dr. Leider has been a force for change in the healthcare industry, helping to establish the disease management specialty for Medicare recipients and other populations with special needs.  He had senior leadership roles in multiple managed care and disease management organizations such as HealthNet, XLHealth, and Harvard Community Health Plan.  As a clinician, he served for six years as an attending physician at Brigham and Women’s Hospital in Boston, and as a faculty member at Harvard Medical School.  Dr. Leider is currently a Senior Scholar in the School of Population Health at Thomas Jefferson University.

A frequent speaker at national meetings and conferences, Dr. Leider has authored numerous peer-reviewed articles and book chapters including: The Essentials of Medical Management and Practicing Medicine in the 21st Century.  He currently serves on the board of the American College of Physician Executives (ACPE) and is the organization’s incoming president and board chairman.  Dr. Leider was a founding board member of the Disease Management Association of America (DMAA), and serves on the board of the Institute of Aging at the University of Pennsylvania.

Dr. Leider earned his BA from Pennsylvania State University, his MD from the University of Pennsylvania School of Medicine, and while a Robert Wood Johnson Clinical Scholar, earned his MBA from the University of Washington.  In addition to being board-certified in Internal Medicine, he is also board-certified in Medical Management.